| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.983 | 0.001 | 0.983 | Phosphodiesterase 4A inhibitor | |||
| 0.908 | 0.003 | 0.908 | Phosphodiesterase inhibitor | |||
| 0.725 | 0.003 | 0.725 | HIV-1 reverse transcriptase inhibitor | |||
| 0.546 | 0.004 | 0.546 | Chelator | 0.099 0.079 CID_131770061 | ||
| 0.542 | 0.004 | 0.542 | DNA directed RNA polymerase inhibitor | |||
| 0.523 | 0.008 | 0.523 | Peroxidase inhibitor | |||
| 0.526 | 0.019 | 0.526 | GABA C receptor rho-3 antagonist | |||
| 0.507 | 0.003 | 0.507 | HIV-1 integrase inhibitor | |||
| 0.48 | 0.016 | 0.48 | Tumour necrosis factor alpha release inhibitor | 0.435 0.021 CID_131770061 | ||
| 0.437 | 0.004 | 0.437 | Phosphodiesterase 4D inhibitor | |||
| 0.477 | 0.045 | 0.477 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.426 | 0.005 | 0.426 | 5-Lipoxygenase inhibitor | |||
| 0.335 | 0.005 | 0.335 | Carbonic anhydrase III inhibitor | 0.208 0.015 CID_131770061 | ||
| 0.325 | 0.007 | 0.363 | Nitric-oxide synthase stimulant | 0.363 0.004 CID_131770061 | CID_131770061 | |
| 0.324 | 0.008 | 0.324 | GABA C receptor agonist | 0.157 0.031 CID_131770061 | ||
| 0.367 | 0.053 | 0.367 | 5 Hydroxytryptamine release stimulant | 0.32 0.064 CID_131770061 | ||
| 0.324 | 0.014 | 0.694 | Alpha-N-acetylglucosaminidase inhibitor | 0.694 0.003 CID_131770061 | CID_131770061 | |
| 0.306 | 0.005 | 0.306 | Phosphodiesterase IV inhibitor | |||
| 0.405 | 0.108 | 0.542 | Caspase 9 stimulant | 0.542 0.047 CID_131770061 | CID_131770061 | |
| 0.327 | 0.036 | 0.387 | Interleukin agonist | 0.387 0.021 CID_131770061 | CID_131770061 | |
| 0.311 | 0.028 | 0.311 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.376 | 0.094 | 0.472 | 5 Hydroxytryptamine release inhibitor | 0.472 0.042 CID_131770061 | CID_131770061 | |
| 0.336 | 0.055 | 0.336 | Lipoxygenase inhibitor | |||
| 0.313 | 0.038 | 0.313 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.321 | 0.047 | 0.321 | Insulysin inhibitor | |||
| 0.36 | 0.097 | 0.68 | Antibacterial | 0.68 0.01 CID_131770061 | CID_131770061 | |
| 0.288 | 0.028 | 0.306 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.306 0.022 CID_131770061 | CID_131770061 | |
| 0.324 | 0.067 | 0.324 | 12-Lipoxygenase inhibitor | |||
| 0.301 | 0.052 | 0.553 | Free radical scavenger | 0.553 0.011 CID_131770061 | CID_131770061 | |
| 0.32 | 0.073 | 0.32 | Calcium channel activator | |||
| 0.327 | 0.084 | 0.515 | Vasodilator, peripheral | 0.515 0.025 CID_131770061 | CID_131770061 | |
| 0.307 | 0.064 | 0.307 | Aldehyde oxidase inhibitor | |||
| 0.247 | 0.009 | 0.247 | Carbonic anhydrase VI inhibitor | 0.126 0.027 CID_131770061 | ||
| 0.275 | 0.053 | 0.453 | DNA synthesis inhibitor | 0.453 0.017 CID_131770061 | CID_131770061 | |
| 0.23 | 0.009 | 0.23 | Porphobilinogen synthase inhibitor | |||
| 0.278 | 0.059 | 0.278 | Superoxide dismutase inhibitor | |||
| 0.278 | 0.067 | 0.286 | DNA damaging | 0.286 0.063 CID_131770061 | CID_131770061 | |
| 0.235 | 0.024 | 0.235 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.224 | 0.015 | 0.475 | UDP-glucose 4-epimerase inhibitor | 0.475 0.003 CID_131770061 | CID_131770061 | |
| 0.208 | 0.007 | 0.208 | Phosphodiesterase 4B inhibitor | |||
| 0.218 | 0.021 | 0.218 | GABA C receptor rho-2 antagonist | |||
| 0.317 | 0.12 | 0.317 | 15-Lipoxygenase inhibitor | |||
| 0.209 | 0.013 | 0.209 | Carbonic anhydrase XIII inhibitor | 0.166 0.019 CID_131770061 | ||
| 0.197 | 0.005 | 0.197 | Carbonic anhydrase VB inhibitor | |||
| 0.217 | 0.026 | 0.263 | ATPase inhibitor | 0.263 0.011 CID_131770061 | CID_131770061 | |
| 0.21 | 0.02 | 0.21 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.222 | 0.034 | 0.222 | Succinate dehydrogenase inhibitor | 0.147 0.119 CID_131770061 | ||
| 0.194 | 0.007 | 0.194 | Alcohol oxidase inhibitor | 0.1 0.018 CID_131770061 | ||
| 0.207 | 0.021 | 0.207 | Ferrochelatase inhibitor | |||
| 0.199 | 0.013 | 0.199 | GABA C receptor antagonist | |||
| 0.211 | 0.026 | 0.329 | Cell wall synthesis inhibitor | 0.329 0.009 CID_131770061 | CID_131770061 | |
| 0.284 | 0.102 | 0.652 | Cholesterol antagonist | 0.652 0.012 CID_131770061 | CID_131770061 | |
| 0.238 | 0.057 | 0.287 | RNA-directed DNA polymerase inhibitor | 0.287 0.034 CID_131770061 | CID_131770061 | |
| 0.177 | 0.005 | 0.177 | Protein kinase B beta inhibitor | |||
| 0.18 | 0.013 | 0.418 | Triose-phosphate isomerase inhibitor | 0.418 0.003 CID_131770061 | CID_131770061 | |
| 0.194 | 0.028 | 0.194 | Glutamate receptor antagonist | |||
| 0.188 | 0.026 | 0.188 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.17 | 0.009 | 0.17 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.168 | 0.011 | 0.168 | Carbonic anhydrase V inhibitor | |||
| 0.171 | 0.017 | 0.204 | DNA repair enzyme inhibitor | 0.204 0.008 CID_131770061 | CID_131770061 | |
| 0.163 | 0.009 | 0.163 | Dopamine D4 agonist | |||
| 0.167 | 0.015 | 0.167 | GABA C receptor rho-1 antagonist | |||
| 0.188 | 0.036 | 0.286 | Monophenol monooxygenase inhibitor | 0.286 0.019 CID_131770061 | CID_131770061 | |
| 0.166 | 0.016 | 0.182 | Ca2+-transporting ATPase inhibitor | 0.182 0.006 CID_131770061 | CID_131770061 | |
| 0.22 | 0.071 | 0.22 | Pyruvate kinase inhibitor | |||
| 0.175 | 0.028 | 0.175 | Aminopeptidase B inhibitor | |||
| 0.265 | 0.119 | 0.537 | Vasodilator, coronary | 0.537 0.011 CID_131770061 | CID_131770061 | |
| 0.183 | 0.04 | 0.183 | NADPH oxidase inhibitor | |||
| 0.151 | 0.009 | 0.151 | Leukotriene synthesis inhibitor | |||
| 0.151 | 0.01 | 0.151 | Carbonic anhydrase VA inhibitor | |||
| 0.164 | 0.025 | 0.164 | MAP kinase 8 inhibitor | |||
| 0.148 | 0.008 | 0.148 | DNA gyrase inhibitor | |||
| 0.191 | 0.055 | 0.191 | Heat shock protein 90 alpha antagonist | |||
| 0.273 | 0.139 | 0.54 | Histamine release inhibitor | 0.54 0.018 CID_131770061 | CID_131770061 | |
| 0.139 | 0.007 | 0.139 | AMPA receptor antagonist | |||
| 0.136 | 0.004 | 0.136 | Glutamate (mGluR4) antagonist | |||
| 0.182 | 0.051 | 0.182 | Arachidonic acid antagonist | 0.163 0.073 CID_131770061 | ||
| 0.131 | 0.003 | 0.131 | Kainate receptor 4 antagonist | |||
| 0.16 | 0.037 | 0.211 | Cystathionine beta-synthase inhibitor | 0.211 0.022 CID_131770061 | CID_131770061 | |
| 0.127 | 0.004 | 0.127 | Kainate receptor 5 antagonist | |||
| 0.175 | 0.053 | 0.259 | Lipid peroxidase inhibitor | 0.259 0.025 CID_131770061 | CID_131770061 | |
| 0.149 | 0.027 | 0.163 | Adenylate kinase inhibitor | 0.163 0.022 CID_131770061 | CID_131770061 | |
| 0.17 | 0.049 | 0.247 | Mannose-6-phosphate isomerase inhibitor | 0.247 0.013 CID_131770061 | CID_131770061 | |
| 0.13 | 0.01 | 0.226 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.226 0.006 CID_131770061 | CID_131770061 | |
| 0.125 | 0.005 | 0.125 | Aconitate hydratase inhibitor | 0.058 0.028 CID_131770061 | ||
| 0.13 | 0.011 | 0.13 | NMDA receptor agonist | |||
| 0.144 | 0.026 | 0.144 | Creatine kinase inhibitor | |||
| 0.117 | 0.004 | 0.117 | DNA topoisomerase IV inhibitor | |||
| 0.193 | 0.081 | 0.193 | Histone acetyltransferase inhibitor | |||
| 0.114 | 0.002 | 0.114 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.032 CID_131770061 | ||
| 0.115 | 0.005 | 0.115 | Glutamate (mGluR group III) antagonist | |||
| 0.146 | 0.038 | 0.146 | 5 Hydroxytryptamine 3A agonist | |||
| 0.117 | 0.01 | 0.117 | NMDA receptor glycine site agonist | |||
| 0.138 | 0.031 | 0.283 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.283 0.007 CID_131770061 | CID_131770061 | |
| 0.13 | 0.023 | 0.13 | CYP2A6 inhibitor | |||
| 0.174 | 0.068 | 0.211 | Phospholipase C inhibitor | 0.211 0.038 CID_131770061 | CID_131770061 | |
| 0.157 | 0.052 | 0.157 | Adenylate cyclase stimulant | 0.15 0.063 CID_131770061 | ||
| 0.189 | 0.087 | 0.237 | Neurotrophic factor enhancer | 0.237 0.047 CID_131770061 | CID_131770061 | |
| 0.126 | 0.025 | 0.387 | NADH dehydrogenase inhibitor | 0.387 0.005 CID_131770061 | CID_131770061 | |
| 0.123 | 0.024 | 0.123 | Metalloproteinase-9 inhibitor | |||
| 0.104 | 0.004 | 0.104 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.125 | 0.026 | 0.125 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.114 | 0.015 | 0.114 | Biliverdin reductase inhibitor | 0.114 0.015 CID_131770061 | ||
| 0.104 | 0.007 | 0.104 | Farnesyltransferase inhibitor | |||
| 0.104 | 0.009 | 0.104 | Glutamate (mGluR7) antagonist | |||
| 0.122 | 0.027 | 0.122 | Interleukin 12 antagonist | 0.089 0.074 CID_131770061 | ||
| 0.135 | 0.041 | 0.135 | Protein kinase C gamma inhibitor | |||
| 0.115 | 0.023 | 0.115 | Keratolytic | 0.086 0.042 CID_131770061 | ||
| 0.178 | 0.088 | 0.296 | Anesthetic general | 0.296 0.034 CID_131770061 | CID_131770061 | |
| 0.112 | 0.022 | 0.112 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.178 | 0.089 | 0.314 | Non-steroidal antiinflammatory agent | 0.314 0.025 CID_131770061 | CID_131770061 | |
| 0.113 | 0.023 | 0.113 | Glutamate decarboxylase inhibitor | |||
| 0.113 | 0.027 | 0.309 | Phosphofructokinase-1 inhibitor | 0.309 0.005 CID_131770061 | CID_131770061 | |
| 0.166 | 0.081 | 0.166 | Tumour necrosis factor antagonist | |||
| 0.115 | 0.031 | 0.115 | Metalloproteinase-2 inhibitor | |||
| 0.099 | 0.017 | 0.099 | Glutamate (mGluR1) antagonist | |||
| 0.097 | 0.016 | 0.097 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.123 | 0.042 | 0.123 | DOPA decarboxylase inhibitor | |||
| 0.1 | 0.02 | 0.1 | Carbamoyl phosphate synthetase inhibitor | 0.098 0.021 CID_131770061 | ||
| 0.125 | 0.045 | 0.156 | Xanthine oxidase inhibitor | 0.156 0.032 CID_131770061 | CID_131770061 | |
| 0.101 | 0.021 | 0.101 | CC chemokine 5 receptor agonist | |||
| 0.103 | 0.026 | 0.103 | Aminopeptidase I inhibitor | |||
| 0.116 | 0.04 | 0.144 | Uric acid excretion stimulant | 0.144 0.025 CID_131770061 | CID_131770061 | |
| 0.095 | 0.021 | 0.095 | GABA B receptor agonist | |||
| 0.08 | 0.008 | 0.08 | Potassium channel (Inward rectifier) activator | |||
| 0.092 | 0.021 | 0.092 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.152 | 0.08 | 0.352 | Thrombolytic | 0.352 0.016 CID_131770061 | CID_131770061 | |
| 0.12 | 0.049 | 0.133 | Acetylcholine release stimulant | 0.133 0.03 CID_131770061 | CID_131770061 | |
| 0.092 | 0.023 | 0.092 | Ribonucleotide reductase inhibitor | |||
| 0.077 | 0.008 | 0.077 | Potassium channel (ATP-sensitive) activator | |||
| 0.207 | 0.138 | 0.207 | Gastrin inhibitor | |||
| 0.109 | 0.04 | 0.109 | Potassium channel activator | |||
| 0.112 | 0.044 | 0.112 | Prolactin inhibitor | |||
| 0.077 | 0.01 | 0.133 | Glucose-6-phosphate isomerase inhibitor | 0.133 0.003 CID_131770061 | CID_131770061 | |
| 0.099 | 0.031 | 0.105 | Glutamate dehydrogenase inhibitor | 0.105 0.028 CID_131770061 | CID_131770061 | |
| 0.11 | 0.045 | 0.11 | Electrolyte absorption antagonist | |||
| 0.112 | 0.048 | 0.112 | Anabolic | 0.093 0.074 CID_131770061 | ||
| 0.083 | 0.021 | 0.083 | Glutamate (mGluR6) antagonist | 0.071 0.037 CID_131770061 | ||
| 0.072 | 0.012 | 0.072 | Pregnane X receptor antagonist | |||
| 0.083 | 0.023 | 0.083 | NMDA 2C receptor antagonist | |||
| 0.099 | 0.039 | 0.099 | Catalase inhibitor | |||
| 0.083 | 0.023 | 0.083 | Xanthine dehydrogenase inhibitor | |||
| 0.125 | 0.066 | 0.176 | Aldehyde dehydrogenase inhibitor | 0.176 0.035 CID_131770061 | CID_131770061 | |
| 0.102 | 0.044 | 0.102 | Histamine N-methyltransferase inhibitor | |||
| 0.143 | 0.087 | 0.322 | Interferon gamma antagonist | 0.322 0.017 CID_131770061 | CID_131770061 | |
| 0.11 | 0.056 | 0.11 | Urease inhibitor | |||
| 0.073 | 0.019 | 0.11 | Carbonic anhydrase XIV inhibitor | 0.11 0.009 CID_131770061 | CID_131770061 | |
| 0.083 | 0.03 | 0.083 | Neutrophil collagenase inhibitor | |||
| 0.076 | 0.024 | 0.076 | Acyl-CoA dehydrogenase inhibitor | 0.058 0.034 CID_131770061 | ||
| 0.077 | 0.027 | 0.083 | Argininosuccinate synthase inhibitor | 0.083 0.024 CID_131770061 | CID_131770061 | |
| 0.061 | 0.011 | 0.061 | Kainate receptor 2 antagonist | |||
| 0.076 | 0.027 | 0.076 | Collagenase 3 inhibitor | |||
| 0.121 | 0.073 | 0.121 | Cathepsin H inhibitor | |||
| 0.072 | 0.025 | 0.072 | Phosphodiesterase 4C inhibitor | |||
| 0.062 | 0.015 | 0.062 | Kainate receptor antagonist | |||
| 0.061 | 0.014 | 0.061 | Dopamine beta hydroxylase inhibitor | |||
| 0.058 | 0.012 | 0.058 | Alpha 1d adrenoreceptor agonist | |||
| 0.085 | 0.039 | 0.085 | Histidine decarboxylase inhibitor | |||
| 0.082 | 0.036 | 0.127 | Glycine receptor agonist | 0.127 0.011 CID_131770061 | CID_131770061 | |
| 0.09 | 0.045 | 0.09 | D-Ala-D-Ala ligase inhibitor | |||
| 0.136 | 0.091 | 0.152 | Heat shock protein 70 antagonist | 0.152 0.041 CID_131770061 | CID_131770061 | |
| 0.081 | 0.036 | 0.081 | Matrix metalloproteinase inhibitor | |||
| 0.076 | 0.031 | 0.076 | Exportin-1 inhibitor | |||
| 0.128 | 0.084 | 0.128 | Neurotrophic factor | |||
| 0.116 | 0.072 | 0.214 | Alkylator | 0.214 0.023 CID_131770061 | CID_131770061 | |
| 0.077 | 0.034 | 0.077 | Cyclin A2 inhibitor | |||
| 0.099 | 0.055 | 0.099 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.073 | 0.03 | 0.08 | Carbonic anhydrase IX inhibitor | 0.08 0.027 CID_131770061 | CID_131770061 | |
| 0.074 | 0.032 | 0.074 | 5 Hydroxytryptamine 3 agonist | |||
| 0.101 | 0.059 | 0.101 | Sphingomyelinase inhibitor | 0.092 0.069 CID_131770061 | ||
| 0.096 | 0.055 | 0.096 | Protein kinase C zeta inhibitor | |||
| 0.087 | 0.046 | 0.087 | Estrogen-related receptor beta agonist | |||
| 0.045 | 0.005 | 0.045 | MAP3K8 inhibitor | |||
| 0.062 | 0.021 | 0.062 | Immunoglobulin Fc receptor antagonist | |||
| 0.053 | 0.013 | 0.053 | AMPA 4 receptor antagonist | |||
| 0.065 | 0.025 | 0.065 | Ryanodine receptor antagonist | |||
| 0.07 | 0.03 | 0.07 | Transcription factor RelA inhibitor | |||
| 0.059 | 0.02 | 0.059 | NMDA receptor subunit 3B antagonist | |||
| 0.091 | 0.053 | 0.091 | NMDA receptor antagonist | |||
| 0.065 | 0.028 | 0.065 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.075 | 0.038 | 0.075 | Protein kinase C beta inhibitor | |||
| 0.145 | 0.109 | 0.145 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.066 | 0.03 | 0.066 | Carbonic anhydrase XII inhibitor | 0.05 0.038 CID_131770061 | ||
| 0.052 | 0.016 | 0.052 | Histamine H1 receptor agonist | |||
| 0.06 | 0.025 | 0.06 | Antimetabolite | 0.051 0.031 CID_131770061 | ||
| 0.081 | 0.047 | 0.081 | Viral attachment inhibitor | |||
| 0.037 | 0.003 | 0.037 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.063 | 0.029 | 0.063 | Matrix metalloproteinase 1 inhibitor | |||
| 0.044 | 0.011 | 0.044 | AMPA 3 receptor antagonist | |||
| 0.07 | 0.037 | 0.07 | Cyclin A inhibitor | |||
| 0.193 | 0.161 | 0.251 | Hypoxia-inducible factor 1 alpha inhibitor | 0.251 0.1 CID_131770061 | CID_131770061 | |
| 0.052 | 0.02 | 0.052 | Geranyltranstransferase inhibitor | |||
| 0.136 | 0.105 | 0.154 | CF transmembrane conductance regulator agonist | 0.154 0.069 CID_131770061 | CID_131770061 | |
| 0.129 | 0.098 | 0.129 | Heat shock protein 90 antagonist | |||
| 0.053 | 0.022 | 0.053 | Macrophage elastase inhibitor | |||
| 0.064 | 0.034 | 0.064 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.074 | 0.044 | 0.074 | Protein kinase B alpha inhibitor | |||
| 0.185 | 0.155 | 0.185 | Transcription factor STAT3 inhibitor | |||
| 0.182 | 0.152 | 0.182 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.048 | 0.019 | 0.048 | Dopamine D5 agonist | |||
| 0.098 | 0.069 | 0.098 | Gastric antisecretory | |||
| 0.04 | 0.012 | 0.067 | Uridine phosphorylase inhibitor | 0.067 0.004 CID_131770061 | CID_131770061 | |
| 0.073 | 0.047 | 0.073 | Phospholipase D inhibitor | |||
| 0.045 | 0.019 | 0.045 | Histone deacetylase 9 inhibitor | |||
| 0.039 | 0.013 | 0.039 | Histone deacetylase class II inhibitor | |||
| 0.043 | 0.018 | 0.043 | Glutamate (mGluR8) agonist | |||
| 0.047 | 0.022 | 0.047 | Nerve growth factor antagonist | |||
| 0.035 | 0.01 | 0.035 | Purinergic P2Y15 antagonist | |||
| 0.081 | 0.056 | 0.081 | Histamine H1 receptor antagonist | |||
| 0.039 | 0.015 | 0.039 | AMPA 1 receptor antagonist | |||
| 0.041 | 0.018 | 0.045 | Fumarate hydratase inhibitor | 0.045 0.016 CID_131770061 | CID_131770061 | |
| 0.047 | 0.023 | 0.047 | GABA B receptor antagonist | |||
| 0.031 | 0.007 | 0.031 | Complement factor 1s inhibitor | |||
| 0.036 | 0.013 | 0.036 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.056 | 0.034 | 0.056 | Thromboxane synthase inhibitor | |||
| 0.04 | 0.018 | 0.04 | RNA-directed RNA polymerase inhibitor | |||
| 0.076 | 0.054 | 0.119 | Na+ K+ transporting ATPase inhibitor | 0.119 0.017 CID_131770061 | CID_131770061 | |
| 0.057 | 0.035 | 0.057 | Dihydroorotate oxidase inhibitor | |||
| 0.044 | 0.022 | 0.044 | Kainate receptor agonist | |||
| 0.062 | 0.041 | 0.062 | Purinergic P2X1 antagonist | 0.06 0.044 CID_131770061 | ||
| 0.034 | 0.014 | 0.034 | Histone deacetylase class IIb inhibitor | |||
| 0.034 | 0.014 | 0.034 | Histone deacetylase 6 inhibitor | |||
| 0.074 | 0.054 | 0.074 | Vanilloid 4 agonist | |||
| 0.055 | 0.035 | 0.055 | Ornithine carbamoyltransferase inhibitor | 0.05 0.04 CID_131770061 | ||
| 0.045 | 0.026 | 0.045 | Histone deacetylase 8 inhibitor | |||
| 0.045 | 0.026 | 0.045 | Histamine H2 receptor agonist | |||
| 0.093 | 0.074 | 0.093 | MAP kinase kinase kinase inhibitor | |||
| 0.112 | 0.094 | 0.112 | Antibacterial (Helicobacter pylori) | |||
| 0.031 | 0.012 | 0.031 | NMDA receptor glycine site antagonist | |||
| 0.049 | 0.031 | 0.083 | Cytokine production stimulant | 0.083 0.005 CID_131770061 | CID_131770061 | |
| 0.023 | 0.005 | 0.023 | Egl nine homolog 1 inhibitor | |||
| 0.035 | 0.017 | 0.035 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.023 | 0.005 | 0.023 | CC chemokine 9 receptor antagonist | |||
| 0.035 | 0.017 | 0.035 | AMPA 2 receptor antagonist | |||
| 0.197 | 0.18 | 0.631 | Antithrombotic | 0.631 0.013 CID_131770061 | CID_131770061 | |
| 0.044 | 0.027 | 0.044 | Heme oxygenase inhibitor | |||
| 0.041 | 0.025 | 0.041 | NMDA receptor subunit 3A antagonist | |||
| 0.057 | 0.042 | 0.057 | Botulinum neurotoxin type A inhibitor | |||
| 0.09 | 0.075 | 0.09 | Bronchodilator | |||
| 0.08 | 0.065 | 0.08 | Acetylcholine agonist | |||
| 0.031 | 0.016 | 0.031 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.04 | 0.026 | 0.04 | CF transmembrane conductance regulator antagonist | |||
| 0.105 | 0.092 | 0.105 | Transcription factor STAT6 inhibitor | |||
| 0.06 | 0.046 | 0.06 | Carbonic anhydrase inhibitor | 0.06 0.046 CID_131770061 | ||
| 0.076 | 0.063 | 0.122 | Glycine receptor antagonist | 0.122 0.017 CID_131770061 | CID_131770061 | |
| 0.086 | 0.073 | 0.106 | Glutamate release inhibitor | 0.106 0.035 CID_131770061 | CID_131770061 | |
| 0.067 | 0.055 | 0.067 | Benzodiazepine agonist | |||
| 0.042 | 0.03 | 0.063 | Guanylate cyclase inhibitor | 0.063 0.009 CID_131770061 | CID_131770061 | |
| 0.141 | 0.129 | 0.141 | Death-associated protein kinase 2 inhibitor | |||
| 0.031 | 0.02 | 0.031 | Histone deacetylase 10 inhibitor | |||
| 0.024 | 0.013 | 0.024 | Glutamate (mGluR1a) agonist | |||
| 0.1 | 0.089 | 0.136 | Photosensitizer | 0.136 0.041 CID_131770061 | CID_131770061 | |
| 0.092 | 0.08 | 0.092 | Carbonic anhydrase XV inhibitor | |||
| 0.052 | 0.04 | 0.117 | Alpha-mannosidase inhibitor | 0.117 0.005 CID_131770061 | CID_131770061 | |
| 0.02 | 0.009 | 0.02 | Kainate receptor 3 antagonist | |||
| 0.044 | 0.034 | 0.044 | Adenylate cyclase 1 inhibitor | |||
| 0.038 | 0.028 | 0.038 | Vanilloid 3 antagonist | |||
| 0.128 | 0.118 | 0.204 | Melanin inhibitor | 0.204 0.039 CID_131770061 | CID_131770061 | |
| 0.046 | 0.036 | 0.046 | Benzodiazepine antagonist | |||
| 0.036 | 0.027 | 0.036 | Histone deacetylase 7 inhibitor | |||
| 0.033 | 0.024 | 0.033 | Calcitonin receptor agonist | |||
| 0.02 | 0.011 | 0.02 | Cyclin T1 inhibitor | |||
| 0.03 | 0.023 | 0.03 | Histone deacetylase class IV inhibitor | |||
| 0.03 | 0.023 | 0.03 | Histone deacetylase 11 inhibitor | |||
| 0.026 | 0.019 | 0.026 | Nicotinic acid receptor 2 antagonist | |||
| 0.124 | 0.117 | 0.124 | Pregnane X receptor agonist | |||
| 0.05 | 0.043 | 0.05 | Acetylcholine muscarinic agonist | |||
| 0.029 | 0.023 | 0.029 | Peptide deformylase inhibitor | |||
| 0.024 | 0.018 | 0.024 | Glutamate (mGluR1) agonist | |||
| 0.027 | 0.021 | 0.027 | Glucosylceramidase stimulant | |||
| 0.039 | 0.034 | 0.039 | Carbonic anhydrase IV inhibitor | |||
| 0.037 | 0.032 | 0.037 | GABA uptake inhibitor | |||
| 0.034 | 0.03 | 0.034 | Glutamate (mGluR3) antagonist | |||
| 0.046 | 0.042 | 0.046 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.019 | 0.016 | 0.019 | Kainate receptor 1 antagonist | |||
| 0.096 | 0.093 | 0.121 | Cholesterol synthesis inhibitor | 0.121 0.064 CID_131770061 | CID_131770061 | |
| 0.029 | 0.026 | 0.029 | Histone deacetylase 5 inhibitor | |||
| 0.075 | 0.073 | 0.075 | GABA A receptor agonist | |||
| 0.083 | 0.082 | 0.083 | MAP kinase kinase 1 inhibitor | |||
| 0.027 | 0.026 | 0.027 | Histone deacetylase class IIa inhibitor | |||
| 0.012 | 0.01 | 0.012 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.048 | 0.046 | 0.048 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.036 | 0.035 | 0.036 | Aggrecanase 1 inhibitor | |||
| 0.036 | 0.034 | 0.036 | Membrane dipeptidase inhibitor | |||
| 0.096 | 0.095 | 0.096 | TRPA1 agonist | |||
| 0.017 | 0.015 | 0.017 | CXC chemokine 5 receptor antagonist | |||
| 0.138 | 0.137 | 0.138 | Catenin beta inhibitor | |||
| 0.106 | 0.105 | 0.106 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.176 | 0.175 | 0.176 | Transcription factor STAT inhibitor | |||
| 0.022 | 0.021 | 0.022 | Prostaglandin H2 antagonist | |||
| 0.04 | 0.04 | 0.06 | Adenosine deaminase inhibitor | 0.06 0.021 CID_131770061 | CID_131770061 | |
| 0.04 | 0.041 | 0.137 | Mannosidase inhibitor | 0.137 0.004 CID_131770061 | CID_131770061 | |
| 0.023 | 0.024 | 0.037 | Vanilloid 2 agonist | 0.037 0.005 CID_131770061 | CID_131770061 | |
| 0.015 | 0.017 | 0.026 | Telomerase stimulant | 0.026 0.004 CID_131770061 | CID_131770061 | |
| 0.013 | 0.018 | 0.024 | Ileal bile acid transport inhibitor | 0.024 0.006 CID_131770061 | CID_131770061 | |
| 0.008 | 0.014 | 0.014 | Purinergic P2Y2 agonist | 0.014 0.004 CID_131770061 | CID_131770061 | |
| 0.095 | 0.101 | 0.17 | Microtubule formation inhibitor | 0.17 0.029 CID_131770061 | CID_131770061 | |
| 0.001 | 0.01 | 0.003 | Purinergic P2Y6 agonist | 0.003 0.002 CID_131770061 | CID_131770061 | |
| 0.076 | 0.088 | 0.098 | Alcohol dehydrogenase inhibitor | 0.098 0.055 CID_131770061 | CID_131770061 | |
| 0.015 | 0.029 | 0.035 | Antibiotic Anthracycline-like | 0.035 0.003 CID_131770061 | CID_131770061 | |
| 0.062 | 0.078 | 0.102 | GABA aminotransferase inhibitor | 0.102 0.025 CID_131770061 | CID_131770061 | |
| 0.084 | 0.101 | 0.24 | Beta glucuronidase inhibitor | 0.24 0.009 CID_131770061 | CID_131770061 | |
| 0.148 | 0.168 | 0.572 | Antioxidant | 0.572 0.013 CID_131770061 | CID_131770061 | |
| 0.083 | 0.106 | 0.139 | Mucolytic | 0.139 0.039 CID_131770061 | CID_131770061 | |
| 0.091 | 0.117 | 0.287 | Cyclooxygenase 3 inhibitor | 0.287 0.006 CID_131770061 | CID_131770061 | |
| 0.018 | 0.048 | 0.054 | Arginase inhibitor | 0.054 0.013 CID_131770061 | CID_131770061 | |
| 0.025 | 0.056 | 0.036 | Ceramide glucosyltransferase inhibitor | 0.036 0.023 CID_131770061 | CID_131770061 | |
| 0.081 | 0.119 | 0.337 | Amylase inhibitor | 0.337 0.014 CID_131770061 | CID_131770061 | |
| 0.073 | 0.12 | 0.22 | Topoisomerase II inhibitor | 0.22 0.029 CID_131770061 | CID_131770061 | |
| 0.014 | 0.062 | 0.073 | Sodium/glucose cotransporter 2 inhibitor | 0.073 0.004 CID_131770061 | CID_131770061 | |
| 0.091 | 0.143 | 0.196 | Protein kinase stimulant | 0.196 0.043 CID_131770061 | CID_131770061 | |
| 0.1 | 0.155 | 0.25 | Hexokinase inhibitor | 0.25 0.017 CID_131770061 | CID_131770061 | |
| 0.075 | 0.131 | 0.11 | Phosphodiesterase 6D inhibitor | 0.11 0.036 CID_131770061 | CID_131770061 | |
| 0.047 | 0.104 | 0.064 | Interferon inducer | 0.064 0.045 CID_131770061 | CID_131770061 | |
| 0.034 | 0.093 | 0.055 | Leukotriene B4 antagonist | 0.055 0.035 CID_131770061 | CID_131770061 | |
| 0.035 | 0.102 | 0.101 | Heparanase inhibitor | 0.101 0.004 CID_131770061 | CID_131770061 | |
| 0.009 | 0.077 | 0.018 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.018 0.009 CID_131770061 | CID_131770061 | |
| 0.014 | 0.083 | 0.054 | Sodium/glucose cotransporter inhibitor | 0.054 0.005 CID_131770061 | CID_131770061 | |
| 0.059 | 0.137 | 0.26 | Expectorant | 0.26 0.012 CID_131770061 | CID_131770061 | |
| 0.089 | 0.171 | 0.132 | Phospholipase A2 inhibitor | 0.132 0.097 CID_131770061 | CID_131770061 | |
| 0.049 | 0.132 | 0.076 | Interferon agonist | 0.076 0.059 CID_131770061 | CID_131770061 | |
| 0.106 | 0.195 | 0.156 | Insulin sensitizer | 0.156 0.125 CID_131770061 | CID_131770061 | |
| 0.121 | 0.217 | 0.268 | Cyclic AMP phosphodiesterase inhibitor | 0.268 0.055 CID_131770061 | CID_131770061 | |
| 0.094 | 0.192 | 0.362 | Hemostatic | 0.362 0.01 CID_131770061 | CID_131770061 | |
| 0.104 | 0.212 | 0.437 | Immunostimulant | 0.437 0.04 CID_131770061 | CID_131770061 | |
| 0.136 | 0.244 | 0.487 | Transcription factor NF kappa B inhibitor | 0.487 0.046 CID_131770061 | CID_131770061 | |
| 0.08 | 0.191 | 0.165 | Psychostimulant | 0.165 0.103 CID_131770061 | CID_131770061 | |
| 0.027 | 0.138 | 0.211 | Antineoplastic antibiotic | 0.211 0.019 CID_131770061 | CID_131770061 | |
| 0.045 | 0.157 | 0.744 | Topoisomerase I inhibitor | 0.744 0.002 CID_131770061 | CID_131770061 | |
| 0.087 | 0.211 | 0.219 | DNA methyltransferase I inhibitor | 0.219 0.06 CID_131770061 | CID_131770061 | |
| 0.141 | 0.274 | 0.315 | Alpha-glucosidase inhibitor | 0.315 0.152 CID_131770061 | CID_131770061 | |
| 0.014 | 0.148 | 0.077 | Phosphorylase inhibitor | 0.077 0.018 CID_131770061 | CID_131770061 | |
| 0.09 | 0.24 | 0.174 | Antiamyloidogenic | 0.174 0.12 CID_131770061 | CID_131770061 | |
| 0.084 | 0.236 | 0.238 | DNA methylase inhibitor | 0.238 0.055 CID_131770061 | CID_131770061 | |
| 0.141 | 0.294 | 0.46 | Apoptosis antagonist | 0.46 0.026 CID_131770061 | CID_131770061 | |
| 0.041 | 0.203 | 0.118 | Mediator release inhibitor | 0.118 0.05 CID_131770061 | CID_131770061 | |
| 0.086 | 0.278 | 0.482 | Vasodilator | 0.482 0.013 CID_131770061 | CID_131770061 | |
| 0.029 | 0.236 | 0.147 | Protein-tyrosine phosphatase 1B inhibitor | 0.147 0.047 CID_131770061 | CID_131770061 | |
| 0.073 | 0.287 | 0.266 | Spasmolytic | 0.266 0.085 CID_131770061 | CID_131770061 | |
| 0.019 | 0.235 | 0.076 | Nitric oxide donor | 0.076 0.026 CID_131770061 | CID_131770061 | |
| 0.039 | 0.274 | 0.18 | AMP-activated protein kinase stimulant | 0.18 0.014 CID_131770061 | CID_131770061 | |
| 0.047 | 0.33 | 0.147 | Diuretic | 0.147 0.079 CID_131770061 | CID_131770061 | |
| 0.097 | 0.438 | 0.265 | Caspase 3 stimulant | 0.265 0.1 CID_131770061 | CID_131770061 | |
| 0.022 | 0.375 | 0.129 | DNA intercalator | 0.129 0.053 CID_131770061 | CID_131770061 | |
| 0.006 | 0.37 | 0.056 | Protein 30S ribosomal subunit inhibitor | 0.056 0.007 CID_131770061 | CID_131770061 | |
| 0.099 | 0.476 | 0.704 | Apoptosis agonist | 0.704 0.03 CID_131770061 | CID_131770061 | |
| 0.025 | 0.402 | 0.152 | Protein-tyrosine phosphatase inhibitor | 0.152 0.076 CID_131770061 | CID_131770061 | |
| 0.02 | 0.426 | 0.05 | Factor III inhibitor | 0.05 0.035 CID_131770061 | CID_131770061 | |
| 0.01 | 0.458 | 0.102 | CDK1/cyclin B1 inhibitor | 0.102 0.028 CID_131770061 | CID_131770061 | |
| 0.037 | 0.488 | 0.332 | Insulin secretagoues | 0.332 0.009 CID_131770061 | CID_131770061 | |
| 0.035 | 0.524 | 0.176 | Interleukin 6 antagonist | 0.176 0.058 CID_131770061 | CID_131770061 | |
| 0.021 | 0.524 | 0.247 | Anticoagulant | 0.247 0.039 CID_131770061 | CID_131770061 | |
| 0.022 | 0.528 | 0.111 | Thioredoxin inhibitor | 0.111 0.037 CID_131770061 | CID_131770061 | |
| 0.026 | 0.537 | 0.071 | Lipocortins synthesis agonist | 0.071 0.021 CID_131770061 | CID_131770061 | |
| 0.076 | 0.6 | 0.16 | CC chemokine 6 receptor antagonist | 0.16 0.012 CID_131770061 | CID_131770061 | |
| 0.039 | 0.58 | 0.318 | NOS3 expression enhancer | 0.318 0.015 CID_131770061 | CID_131770061 | |
| 0.012 | 0.57 | 0.095 | Glucose-6-phosphate translocase inhibitor | 0.095 0.007 CID_131770061 | CID_131770061 | |
| 0.014 | 0.577 | 0.082 | Histone deacetylase SIRT1 stimulant | 0.082 0.042 CID_131770061 | CID_131770061 | |
| 0.014 | 0.577 | 0.082 | Histone deacetylase stimulant | 0.082 0.042 CID_131770061 | CID_131770061 | |
| 0.074 | 0.664 | 0.421 | Peptidyltransferase inhibitor | 0.421 0.005 CID_131770061 | CID_131770061 | |
| 0.005 | 0.606 | 0.368 | Selectin antagonist | 0.368 0.004 CID_131770061 | CID_131770061 | |
| 0.028 | 0.665 | 0.501 | Immunosuppressant | 0.501 0.033 CID_131770061 | CID_131770061 | |
| 0.003 | 0.658 | 0.044 | Squalene synthetase inhibitor | 0.044 0.016 CID_131770061 | CID_131770061 | |
| 0.001 | 0.657 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 CID_131770061 | CID_131770061 | |
| 0.002 | 0.679 | 0.021 | Corticosteroid-like | 0.021 0.015 CID_131770061 | CID_131770061 | |
| 0.017 | 0.71 | 0.078 | Adenine nucleotide translocase inhibitor | 0.078 0.01 CID_131770061 | CID_131770061 | |
| 0.025 | 0.729 | 0.162 | Transcription factor NF kappa B stimulant | 0.162 0.014 CID_131770061 | CID_131770061 | |
| 0.026 | 0.786 | 0.709 | Antiinflammatory | 0.709 0.029 CID_131770061 | CID_131770061 | |
| 0.017 | 0.784 | 0.158 | DNA polymerase I inhibitor | 0.158 0.045 CID_131770061 | CID_131770061 | |
| 0.011 | 0.785 | 0.748 | Angiogenesis stimulant | 0.748 0.004 CID_131770061 | CID_131770061 | |
| 0.015 | 0.804 | 0.162 | Toll-Like receptor 4 antagonist | 0.162 0.015 CID_131770061 | CID_131770061 | |
| 0.005 | 0.835 | 0.303 | Platelet antagonist | 0.303 0.052 CID_131770061 | CID_131770061 | |
| 0.014 | 0.854 | 0.402 | Immunomodulator | 0.402 0.043 CID_131770061 | CID_131770061 | |
| 0.039 | 0.909 | 0.467 | Interleukin 2 agonist | 0.467 0.013 CID_131770061 | CID_131770061 | |
| 0.005 | 0.886 | 0.373 | Nitric oxide antagonist | 0.373 0.029 CID_131770061 | CID_131770061 | |
| 0.005 | 0.888 | 0.248 | Hypolipemic | 0.248 0.068 CID_131770061 | CID_131770061 | |
| 0.003 | 0.898 | 0.049 | Microtubule stabilization | 0.049 0.029 CID_131770061 | CID_131770061 | |
| 0.005 | 0.902 | 0.105 | Protein 50S ribosomal subunit inhibitor | 0.105 0.012 CID_131770061 | CID_131770061 | |
| 0.009 | 0.906 | 0.107 | Factor IXa inhibitor | 0.107 0.008 CID_131770061 | CID_131770061 | |
| 0.004 | 0.912 | 0.054 | Neuraminidase (Influenza A) inhibitor | 0.054 0.018 CID_131770061 | CID_131770061 | |
| 0.004 | 0.934 | 0.126 | Topoisomerase II alpha inhibitor | 0.126 0.028 CID_131770061 | CID_131770061 | |
| 0.004 | 0.938 | 0.115 | Cell adhesion molecule inhibitor | 0.115 0.026 CID_131770061 | CID_131770061 | |
| 0.011 | 0.946 | 0.45 | Hepatoprotectant | 0.45 0.01 CID_131770061 | CID_131770061 | |
| 0.004 | 0.94 | 0.08 | Antibiotic Aminoglycoside-like | 0.08 0.004 CID_131770061 | CID_131770061 | |
| 0.011 | 0.952 | 0.128 | Interleukin 4 antagonist | 0.128 0.074 CID_131770061 | CID_131770061 | |
| 0.005 | 0.948 | 0.106 | ATPase (Vacuolar H+) inhibitor | 0.106 0.032 CID_131770061 | CID_131770061 | |
| 0.002 | 0.955 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.024 CID_131770061 | CID_131770061 | |
| 0.005 | 0.964 | 0.682 | Cyclophilin D inhibitor | 0.682 0.016 CID_131770061 | CID_131770061 | |
| 0.005 | 0.966 | 0.035 | Toll-Like receptor 4 agonist | 0.035 0.007 CID_131770061 | CID_131770061 | |
| 0.005 | 0.974 | 0.603 | Hypoglycemic | 0.603 0.008 CID_131770061 | CID_131770061 | |
| 0.003 | 0.972 | 0.074 | Neuraminidase inhibitor | 0.074 0.03 CID_131770061 | CID_131770061 | |
| 0.004 | 0.974 | 0.122 | Multidrug resistance-associated protein 1 inhibitor | 0.122 0.046 CID_131770061 | CID_131770061 | |
| 0.003 | 0.973 | 0.084 | Neuraminidase (influenza) inhibitor | 0.084 0.023 CID_131770061 | CID_131770061 | |
| 0.004 | 0.981 | 0.215 | Cell adhesion inhibitor | 0.215 0.021 CID_131770061 | CID_131770061 | |
| 0.004 | 0.995 | 0.374 | Platelet adhesion inhibitor | 0.374 0.015 CID_131770061 | CID_131770061 | |
| 0.004 | 0.995 | 0.43 | Antiobesity | 0.43 0.055 CID_131770061 | CID_131770061 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |